Position in CRDL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$819,207
+$508,969 QoQ
Shares Held
772,837
+236.3% QoQ
Ownership
0.662%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 52 holders
Holding Since
Sep 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRDL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,860,663 across 49 Drug Manufacturers - Specialty & Generic names. CRDL ranks #36 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in CRDL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $819,207 | 772,837 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $310,238 | 229,806 | Shares | Sole | 2026-05-14 | |
| 2023-03-31 | $4,918 | 10,100 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $172,050 | 93,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $601,335 | 144,900 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||